XML 17 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net revenues $ 2,774 $ 2,786 $ 8,044 $ 6,435
Operating costs and expenses and other operating income:        
Cost of services 1,670 1,580 4,861 4,071
Selling, general and administrative 427 396 1,263 1,103
Amortization of intangible assets 25 27 77 77
Other operating expense (income), net 0 65 (2) 8
Total operating costs and expenses, net 2,122 2,068 6,199 5,259
Operating income 652 718 1,845 1,176
Other income (expense):        
Interest expense, net (38) (42) (114) (124)
Other income, net 40 77 366 74
Total non-operating income (expense), net 2 35 252 (50)
Income before income taxes and equity in earnings of equity method investees 654 753 2,097 1,126
Income tax expense (153) (177) (483) (269)
Equity in earnings of equity method investees, net of taxes 26 15 53 33
Net income 527 591 1,667 890
Less: Net income attributable to noncontrolling interests 22 23 62 38
Net income attributable to Quest Diagnostics $ 505 $ 568 $ 1,605 $ 852
Earnings per share attributable to Quest Diagnostics’ common stockholders:        
Basic(in dollars per share) $ 4.11 $ 4.20 $ 12.63 $ 6.33
Diluted (in dollars per share) $ 4.02 $ 4.14 $ 12.41 $ 6.25
Weighted average common shares outstanding:        
Basic (in Shares) 123 135 127 134
Diluted (in Shares) 125 137 129 136